Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200096 · ClinicalTrials.gov registry record · Phase 3
Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 101
- Enrollment target
NCT00200096: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00200096 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200096, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 101 participants
- Enrollment target
Study Summary
In a previous study, we found that acupuncture may decrease fatigue. The aim of this study is to determine whether acupuncture is helpful in reducing fatigue in cancer patients treated with chemotherapy. We will also study how fatigue, quality of life, mood, level of physical activity. This study will involve about 88 patients.
Interventions
- PROCEDURE placebo acupuncture
- PROCEDURE Acupuncture and questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2004-07 |
| Est. Completion | 2011-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200096
The ClinicalTrials.gov registry entry for NCT00200096 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo acupuncture is the first listed.
NCT00200096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200096 about?
NCT00200096 is a clinical study titled "Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial". In a previous study, we found that acupuncture may decrease fatigue. The aim of this study is to determine whether acupuncture is helpful in reducing fatigue in cancer patients treated with chemotherapy. We will also study how fatigue, quality of life, mood, level of physical activity. This study wi...
What is the current status of trial NCT00200096?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 101 participants. The study started on 2004-07. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00200096?
The interventions under investigation include: placebo acupuncture (PROCEDURE), Acupuncture and questionnaires (PROCEDURE).
Who is sponsoring clinical trial NCT00200096?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.